abstract |
The present invention relates to compositions comprising an inhibitor of human histone methyltransferase EZH2 and one or more other therapeutic agents, especially anticancer agents such as prednisone, and to a subject in need thereof Combination therapy methods administered to patients for the treatment of cancer. |